市場調查報告書
商品編碼
390901

全球末稍血管設備市場:各產品類型、地區 - 成長,趨勢,預測(2018年∼2023年)

Peripheral Vascular Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

出版日期: | 出版商: Mordor Intelligence Pvt Ltd | 英文 115 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

全球末稍血管設備市場,預計從2018年到2023年的調查期間以7.1%的年複合成長率發展。各地區中,心血管疾病的罹患率上升,擁有大型參與企業的北美成為最大市場。

本報告提供末稍血管設備的全球市場調查,市場概要,各產品類型、地區的市場趨勢,市場規模的變化與預測,市場佔有率,市場促進、阻礙因素以及市場機會、課題分析,競爭情形,主要企業的簡介等系統性資訊。

目錄

第1章 簡介

  • 市場定義

第2章 調查方法

第3章 摘要整理

第4章 主要影響要素

第5章 市場概要

  • 目前市場方案
  • 波特的五力分析
    • 買方議價能力
    • 供給企業談判力
    • 新加入業者的威脅
    • 替代品的威脅
    • 競爭企業間的敵對關係

第6章 成長要素,阻礙因素,市場機會,課題分析(DROC)

  • 市場成長要素
    • 末稍血管動脈疾病的的增加微創手術的需求增加
    • 週邊動脈疾病的罹患率上升
    • 生活方式的變化和老年人口的增加
    • 技術發展的末稍血管設備的應用範圍擴大
  • 市場阻礙因素
    • 起因於嚴格法規的產品核可的延遲
    • 末稍血管用設備缺乏恰當的償付制度
    • 市場高片斷化帶來的價格破壞
  • 市場機會
  • 主要課題

第7章 市場區隔

  • 各產品類型
    • 末梢血管支架
    • 末稍血管擴張術(PTA)用球囊導管
    • 末稍血管擴張術(PTA)用導管導引線
    • 旋切術設備
    • 慢性完全閉塞病變(CTO)用設備
    • 主動脈支架
    • 外科用合成移植
    • 栓塞預防設備
    • 下腔靜脈(IVC)過濾器
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第8章 競爭情形

  • 合併、收購分析
  • 協定,合作,夥伴關係
  • 新產品的銷售

第9章 主要企業

  • Abbott Vascular
  • The Boston Scientific Corporation
  • CRBard, Inc.
  • Cook Group
  • Cordis Corporation
  • Covidien PLC
  • Edward Lifesciences
  • Medtronic
  • St. Jude Medical
  • Volcano Corporation

第10章 市場未來展望

目錄
Product Code: 54386

Peripheral arterial disease (PAD) is caused by a narrowing or blocking of the blood vessels, due to a plaque build-up. This condition can lead to tissue death, heart stroke, aneurysms, or kidney diseases, if left untreated.

According to the National Institute of Health, one in every 20 Americans, who are of age 50 years or above, has PAD. It has been affecting 8-12 million people in the United States, especially those over 50 years.

As the population is growing, the prevalence of the disease is also increasing, which may grow from 9.6 million to reach 19 million overall, globally, by 2050. With the aging global population, it is likely that PAD may be increasingly common in the future. Hence, the statistics show that the number of PAD is increasing at a faster pace, which is ultimately driving the market for peripheral arterial disease.

Other factors, such as the rising demand for minimally-invasive procedures, especially for peripheral arterial disease, lifestyle changes, increase in aging population, and technological advancements, have broadened the range of the peripheral vascular devices.

Key Market Trends

Atherectomy Devices are Expected to Dominate the Overall Market

  • The market, on the basis of device type, is segmented into peripheral vascular stents, peripheral transluminal angioplasty (PTA) balloon catheters, peripheral transluminal angioplasty (PTA) guidewires, atherectomy devices, chronic total occlusion (CTO) devices, aortic stents, synthetic surgical grafts, embolic protection devices, and inferior vena cava filters.
  • The atherectomy devices segment is expected to dominate the overall market, owing to the increasing prevalence of atherosclerosis, rising obesity, and lifestyle-related disorders. According to the International Journal of Epidemiology, 2019, almost 75% of myocardial infarctions occur due to plaque rupture, and the incidence is bound to increase in men of age 45 years or above.
  • Additionally, the growing burden of cardiovascular diseases leading to higher morbidity and mortality is expected to influence the market positively, on the peripheral vascular devices market in atherectomy devices.

North America Dominates the Peripheral Vascular Devices Market

  • North America dominated the peripheral vascular devices market in 2019, and it is expected to grow similarly in the future due to factors, like the rising incidence of cardiovascular diseases, growing geriatric population, and the strong presence of industry players in the region.
  • According to the International Journal of Epidemiology, in 2019, around 610,000 people die due to one or the other heart diseases, annually, in the United States. Furthermore, approximately 735,000 people in the United States experience heart attacks, annually.
  • Europe holds the second-largest position in the market studied, which is followed by the APAC region.

Competitive Landscape

The presence of the major market players, such as Abbott Laboratories, Boston Scientific Corporation, Becton, Dickinson and Company, Cook Group, and Medtronic PLC, is intensifying the market competition. The increasing innovation and rise in investment for various public and private organizations are expected to intensify the industry rivalry across the world.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Demand for Minimally-invasive Procedures
    • 4.2.2 Increase in Incidence of Peripheral Arterial Disease (PAD)
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulation Related to Peripheral Vascular Devices
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Device Type
    • 5.1.1 Peripheral Vascular Stents
    • 5.1.2 Peripheral Transluminal Angioplasty (PTA) Balloon Catheters
    • 5.1.3 Peripheral Transluminal Angioplasty (PTA) Guidewires
    • 5.1.4 Atherectomy Devices
    • 5.1.5 Embolic Protection Devices
    • 5.1.6 Inferior Vena Cava Filters
    • 5.1.7 Other Device Types
  • 5.2 Geography
    • 5.2.1 North America
      • 5.2.1.1 United States
      • 5.2.1.2 Canada
      • 5.2.1.3 Mexico
    • 5.2.2 Europe
      • 5.2.2.1 Germany
      • 5.2.2.2 United Kingdom
      • 5.2.2.3 France
      • 5.2.2.4 Italy
      • 5.2.2.5 Spain
      • 5.2.2.6 Rest of Europe
    • 5.2.3 Asia-Pacific
      • 5.2.3.1 China
      • 5.2.3.2 Japan
      • 5.2.3.3 India
      • 5.2.3.4 Australia
      • 5.2.3.5 South Korea
      • 5.2.3.6 Rest of Asia-Pacific
    • 5.2.4 Middle-East and Africa
      • 5.2.4.1 GCC
      • 5.2.4.2 South Africa
      • 5.2.4.3 Rest of Middle-East and Africa
    • 5.2.5 South America
      • 5.2.5.1 Brazil
      • 5.2.5.2 Argentina
      • 5.2.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Boston Scientific Corporation
    • 6.1.3 Becton, Dickinson and Company
    • 6.1.4 Cook Group
    • 6.1.5 Cordis Corporation
    • 6.1.6 Edward Lifesciences
    • 6.1.7 Medtronic PLC
    • 6.1.8 Volcano Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS